Position in SNY
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$322,040
-$14,979 QoQ
Shares Held
7,549
+7.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#404
of 712 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sunpointe, LLC holds $9,495,332 across 8 Drug Manufacturers - General names. SNY ranks #7 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
15,952 | $4,051,329 | |
| 2 | LLY |
ELI LILLY & Co
|
1,268 | $1,520,877 | |
| 3 | ABBV |
AbbVie Inc.
|
4,063 | $1,022,413 | |
| 4 | MRK |
Merck & Co., Inc.
|
7,636 | $981,226 | |
| 5 | PFE |
Pfizer Inc
|
38,069 | $916,701 | |
| 6 | AMGN |
Amgen Inc
|
1,045 | $378,415 | |
| 7 | SNY |
Sanofi
This page
|
7,549 | $322,040 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,393 | $302,331 |
All Filings in SNY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $322,040 | 7,549 | Shares | Defined | 2026-07-24 | |
| 2026-03-31 | $337,019 | 6,995 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $259,067 | 5,346 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $252,614 | 5,352 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $309,618 | 6,409 | Shares | Defined | 2025-07-09 | |
| 2025-03-31 | $298,042 | 5,374 | Shares | Defined | 2025-05-07 | |
| 2024-12-31 | $228,513 | 4,738 | Shares | Defined | 2025-02-03 | |
| 2024-09-30 | $268,152 | 4,653 | Shares | Defined | 2024-10-16 | |
| 2024-06-30 | $226,297 | 4,664 | Shares | Defined | 2024-07-22 | |
| No filing history on record for this holder in this stock. | ||||||